AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway. 

Shimadzu Medical Systems USA released the latest version of its Trinias angiography system at the Radiological Society of North America (RSNA) 2022 meeting to address radiation concerns and to help improve workflow.
 

To address radiation concerns by interventionalists and to help speed workflows in cath labs, Shimadzu released new AI features and single button push features for table and C-arm movement. 

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

The new-look adjustable stents, not yet fully approved by the FDA, can be expanded as a child ages. The hope is that these stents will never need to be replaced.

One patient received a total of 41 stents from 2004 to 2013. He said the experience was so hard that he feared he would be driven to suicide. 

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.